234 related articles for article (PubMed ID: 21148689)
21. Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant
Lehman SM; Mearns G; Rankin D; Cole RA; Smrekar F; Branston SD; Morales S
Viruses; 2019 Jan; 11(1):. PubMed ID: 30669652
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the genetic switch from phage ɸ13 important for Staphylococcus aureus colonization in humans.
Kristensen CS; Varming AK; Leinweber HAK; Hammer K; Lo Leggio L; Ingmer H; Kilstrup M
Microbiologyopen; 2021 Oct; 10(5):e1245. PubMed ID: 34713608
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of a novel Staphylococcus aureus bacteriophage, phiMR25, and its therapeutic potential.
Hoshiba H; Uchiyama J; Kato S; Ujihara T; Muraoka A; Daibata M; Wakiguchi H; Matsuzaki S
Arch Virol; 2010 Apr; 155(4):545-52. PubMed ID: 20224894
[TBL] [Abstract][Full Text] [Related]
24. Comparative Genomics of Three Novel Jumbo Bacteriophages Infecting Staphylococcus aureus.
Korn AM; Hillhouse AE; Sun L; Gill JJ
J Virol; 2021 Sep; 95(19):e0239120. PubMed ID: 34287047
[TBL] [Abstract][Full Text] [Related]
25. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus.
O'Flaherty S; Coffey A; Meaney W; Fitzgerald GF; Ross RP
J Bacteriol; 2005 Oct; 187(20):7161-4. PubMed ID: 16199588
[TBL] [Abstract][Full Text] [Related]
26. APTC-C-SA01: A Novel Bacteriophage Cocktail Targeting
Liu S; Hon K; Bouras GS; Psaltis AJ; Shearwin K; Wormald PJ; Vreugde S
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682794
[TBL] [Abstract][Full Text] [Related]
27. Morphologic and genomic characterization of a broad host range Salmonella enterica serovar Pullorum lytic phage vB_SPuM_SP116.
Bao H; Shahin K; Zhang Q; Zhang H; Wang Z; Zhou Y; Zhang X; Zhu S; Stefan S; Wang R
Microb Pathog; 2019 Nov; 136():103659. PubMed ID: 31398528
[TBL] [Abstract][Full Text] [Related]
28. Correlation of Host Range Expansion of Therapeutic Bacteriophage Sb-1 with Allele State at a Hypervariable Repeat Locus.
Sergueev KV; Filippov AA; Farlow J; Su W; Kvachadze L; Balarjishvili N; Kutateladze M; Nikolich MP
Appl Environ Microbiol; 2019 Nov; 85(22):. PubMed ID: 31492663
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of a new Staphylococcus epidermidis broad-spectrum bacteriophage.
Melo LDR; Sillankorva S; Ackermann HW; Kropinski AM; Azeredo J; Cerca N
J Gen Virol; 2014 Feb; 95(Pt 2):506-515. PubMed ID: 24189619
[TBL] [Abstract][Full Text] [Related]
30. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals.
O'Flaherty S; Ross RP; Meaney W; Fitzgerald GF; Elbreki MF; Coffey A
Appl Environ Microbiol; 2005 Apr; 71(4):1836-42. PubMed ID: 15812009
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.
Zhang Y; Cheng M; Zhang H; Dai J; Guo Z; Li X; Ji Y; Cai R; Xi H; Wang X; Xue Y; Sun C; Feng X; Lei L; Han W; Gu J
Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776929
[TBL] [Abstract][Full Text] [Related]
32. Characterization and complete genome sequence analysis of Staphylococcus aureus bacteriophage SA12.
Chang Y; Lee JH; Shin H; Heu S; Ryu S
Virus Genes; 2013 Oct; 47(2):389-93. PubMed ID: 23775760
[TBL] [Abstract][Full Text] [Related]
33. Peculiarities of Staphylococcus aureus phages and their possible application in phage therapy.
Azam AH; Tanji Y
Appl Microbiol Biotechnol; 2019 Jun; 103(11):4279-4289. PubMed ID: 30997551
[TBL] [Abstract][Full Text] [Related]
34. Use of phages against antibiotic-resistant Staphylococcus aureus isolated from bovine mastitis.
Dias RS; Eller MR; Duarte VS; Pereira ÂL; Silva CC; Mantovani HC; Oliveira LL; Silva Ede A; De Paula SO
J Anim Sci; 2013 Aug; 91(8):3930-9. PubMed ID: 23893999
[TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of a potentially novel Siphoviridae phage (vB_SsapS-104) with lytic activity against Staphylococcus saprophyticus isolated from urinary tract infection.
Yazdi M; Bouzari M; Ghaemi EA
Folia Microbiol (Praha); 2019 May; 64(3):283-294. PubMed ID: 30284669
[TBL] [Abstract][Full Text] [Related]
36. Staphylococcal Phage in Combination with Staphylococcus Epidermidis as a Potential Treatment for Staphylococcus Aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants.
Shimamori Y; Mitsunaka S; Yamashita H; Suzuki T; Kitao T; Kubori T; Nagai H; Takeda S; Ando H
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375201
[TBL] [Abstract][Full Text] [Related]
37. Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5.
Rodríguez-Rubio L; Martínez B; Rodríguez A; Donovan DM; García P
Appl Environ Microbiol; 2012 Apr; 78(7):2241-8. PubMed ID: 22267667
[TBL] [Abstract][Full Text] [Related]
38. Genes Influencing Phage Host Range in Staphylococcus aureus on a Species-Wide Scale.
Moller AG; Winston K; Ji S; Wang J; Hargita Davis MN; Solís-Lemus CR; Read TD
mSphere; 2021 Jan; 6(1):. PubMed ID: 33441407
[No Abstract] [Full Text] [Related]
39. Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme.
Son JS; Lee SJ; Jun SY; Yoon SJ; Kang SH; Paik HR; Kang JO; Choi YJ
Appl Microbiol Biotechnol; 2010 May; 86(5):1439-49. PubMed ID: 20013118
[TBL] [Abstract][Full Text] [Related]
40. Synergistic action of phage phiIPLA-RODI and lytic protein CHAPSH3b: a combination strategy to target Staphylococcus aureus biofilms.
Duarte AC; Fernández L; De Maesschalck V; Gutiérrez D; Campelo AB; Briers Y; Lavigne R; Rodríguez A; García P
NPJ Biofilms Microbiomes; 2021 Apr; 7(1):39. PubMed ID: 33888725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
